Literature DB >> 2534967

Down-regulation of proopiomelanocortin synthesis and beta-endorphin utilization in hypothalamus of morphine-tolerant rats.

I Mocchetti1, A Ritter, E Costa.   

Abstract

We investigated regulation of the dynamic state of enkephalin and endorphin brain stores during morphine tolerance and dependence using cDNA hybridization and radioimmunoassay of the biologically active peptide(s) and their respective peptide precursors. Rats were made tolerant to morphine with the subcutaneous implantation of three morphine pellets (75 mg each) for a period of five days. Hypothalamic proopiomelanocortin (POMC) mRNA, POMC, and corticotropin-like intermediate lobe peptide content were decreased by 50% in morphine-dependent rats. However, beta-endorphin content remained unchanged. Enkephalin and proenkephalin mRNA content in various brain structures failed to change. A single injection of naltrexone (2 mg/kg) 1 hour before decapitation did not reverse the decrease in POMC mRNA and POMC content elicited by morphine. However, a slower, spontaneous withdrawal caused by removal of the pellets did reverse (after two days) the down-regulation of the hypothalamic POMC system. A single injection of morphine (10 mg/kg) failed to affect any parameter used to assess the dynamic state of opioid peptides.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2534967     DOI: 10.1007/bf02896854

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  26 in total

1.  Distribution of beta-endorphin and related peptides in the hypothalamus and pituitary.

Authors:  W Fratta; H Y Yang; B Majane; E Costa
Journal:  Neuroscience       Date:  1979       Impact factor: 3.590

2.  Neurons containing beta-endorphin in rat brain exist separately from those containing enkephalin: immunocytochemical studies.

Authors:  F Bloom; E Battenberg; J Rossier; N Ling; R Guillemin
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

3.  Formulation of a morphine implantation pellet suitable for tolerance-physical dependence studies in mice.

Authors:  R D Gibson; J E Tingstad
Journal:  J Pharm Sci       Date:  1970-03       Impact factor: 3.534

4.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

5.  Stability of Met-enkephalin content in brain structures of morphine-dependent or foot shock-stressed rats.

Authors:  W Fratta; H Y Yang; J Hong; E Costa
Journal:  Nature       Date:  1977-08-04       Impact factor: 49.962

6.  Environmental modulation of analgesic tolerance induced by morphine pellets.

Authors:  C Advokat
Journal:  Pharmacol Biochem Behav       Date:  1981-02       Impact factor: 3.533

7.  Pharmacokinetics and pharmacodynamics of subcutaneous morphine pellets in the rat.

Authors:  B C Yoburn; J Chen; T Huang; C E Inturrisi
Journal:  J Pharmacol Exp Ther       Date:  1985-11       Impact factor: 4.030

8.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

9.  The distribution of enkephalin-immunoreactive cell bodies in the rat central nervous system.

Authors:  T Hökfelt; R Elde; O Johansson; L Terenius; L Stein
Journal:  Neurosci Lett       Date:  1977-06       Impact factor: 3.046

10.  Phosphorylation of rat and human adrenocorticotropin-related peptides: physiological regulation and studies of secretion.

Authors:  R E Mains; B A Eipper
Journal:  Endocrinology       Date:  1983-06       Impact factor: 4.736

View more
  8 in total

1.  Effects of prolonged treatment with the opiate tramadol on prodynorphin gene expression in rat CNS.

Authors:  Sanzio Candeletti; Giuseppe Lopetuso; Rosalia Cannarsa; Chiara Cavina; Patrizia Romualdi
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 2.  Pharmacological regulation of gene expression.

Authors:  Italo Mocchetti
Journal:  Pharmacol Res       Date:  2011-06-16       Impact factor: 7.658

3.  Tolerance develops in spinal cord, but not in brain with chronic [Dmt1]DALDA treatment.

Authors:  Yong Ben; Andrew P Smith; Peter W Schiller; Nancy M Lee
Journal:  Br J Pharmacol       Date:  2004-11-22       Impact factor: 8.739

Review 4.  Reward processing by the opioid system in the brain.

Authors:  Julie Le Merrer; Jérôme A J Becker; Katia Befort; Brigitte L Kieffer
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

5.  Proopiomelanocortin (POMC) expression and conditioned place aversion during protracted withdrawal from chronic intermittent escalating-dose heroin in POMC-EGFP promoter transgenic mice.

Authors:  K Niikura; Y Zhou; A Ho; M J Kreek
Journal:  Neuroscience       Date:  2013-01-18       Impact factor: 3.590

6.  Differential time course of effects of kappa-opioid agonist treatment on dynorphin A levels and kappa-opioid receptor density.

Authors:  Claudio D'Addario; Manuela Di Benedetto; Sari Izenwasser; Sanzio Candeletti; Patrizia Romualdi
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

7.  Suppression of hypothalamic-pituitary-adrenal axis by acute heroin challenge in rats during acute and chronic withdrawal from chronic heroin administration.

Authors:  Yan Zhou; Francesco Leri; Ann Ho; Mary Jeanne Kreek
Journal:  Neurochem Res       Date:  2013-06-16       Impact factor: 3.996

Review 8.  Drug-induced and genetic alterations in stress-responsive systems: Implications for specific addictive diseases.

Authors:  Yan Zhou; Dmitri Proudnikov; Vadim Yuferov; Mary Jeanne Kreek
Journal:  Brain Res       Date:  2009-11-12       Impact factor: 3.252

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.